Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?Zacks Investment Research • 06/26/26
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy24/7 Wall Street • 06/25/26
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy24/7 Wall Street • 06/24/26
MiniMed Launches Abbott's Instinct Sensors Across European MarketsZacks Investment Research • 06/24/26
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease TestingPRNewsWire • 06/24/26
Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher courtReuters • 06/23/26
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parentsPRNewsWire • 06/22/26
The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War LevelsBenzinga • 06/15/26
Abbott (ABT) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 06/12/26
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workersPRNewsWire • 06/08/26